skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Búsqueda Sencilla
Resultados 1 2 3 4 5 next page
Mostrar solo
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Markers of inflammation predict mortality and are reduced by pexelizumab in patients with acute myocardial infarction insights from the complement inhibition in myocardial infartion treated with angiooplasty (COMMA) trial
Markers of inflammation predict mortality and are reduced by pexelizumab in patients with acute myocardial infarction insights from the complement inhibition in myocardial infartion treated with angiooplasty (COMMA) trial
Material Type:
Artículo de Congreso 		Añadir a Mi Portal

Markers of inflammation predict mortality and are reduced by pexelizumab in patients with acute myocardial infarction insights from the complement inhibition in myocardial infartion treated with angiooplasty (COMMA) trial

Pierre Theroux Paul W Armstrong; Lina M Gonzales; Kenneth W Mahaffey; Judith S Hochman; Scott Rollins; Kevin J Malloy; Thomas Parish; José Carlos Nicolau; Joel Lavoie; Christopher B Granger; Annual Scientific Session American College of Cardiology (53. 2004 New Orleans, EUA)

Journal American College of Cardiology New York v.43, suppl. A, p. 287A, res. 833-5, 2004

New York 2004

Disponible en FM - Fac. Medicina    (BCSEP 2004 65 ) y otras localizaciones(Obténgalo)

2
The occluded artery trial(OAT)viability ancillary study(OAT-NUC) influence of infarct zone viability on left ventricular remodeling after PCI vs. medical therapy alone
The occluded artery trial(OAT)viability ancillary study(OAT-NUC) influence of infarct zone viability on left ventricular remodeling after PCI vs. medical therapy alone
Material Type:
Artículo de Congreso 		Añadir a Mi Portal

The occluded artery trial(OAT)viability ancillary study(OAT-NUC) influence of infarct zone viability on left ventricular remodeling after PCI vs. medical therapy alone

James E. Udelson Camille A Pearte; Carey D Kimmelstiel; Mariusz Kruk; Anna Teresinska; Bartosz Bychowiec; José Antônio Marin-Neto; Thomas Höchtl; Eric A Cohen; Paulo Caramori; Benita Busz-Papiez; Christopher Adlbrecht; Zygmunt Sadowski; Witold Ruzyllo; Sandy A Forman; Debora J Kinan; Gervasio A Lamas; Judith S Hochman; Scientific Sessions of The American Heart Association(AHA) (2007 Orlando)

Abstracts Orlando, 2007

Orlando 2007

Disponible en FMRP - Fac. Medicina de Ribeirão Preto    (pcd 1642665 ) y otras localizaciones(Obténgalo)

3
Predictors of outcome and the lack of effect of PCI across the risk strata in patients with persistent total occlusion after myocardial infarction results from the occluded artery trial
Predictors of outcome and the lack of effect of PCI across the risk strata in patients with persistent total occlusion after myocardial infarction results from the occluded artery trial
Material Type:
Artículo de Congreso 		Añadir a Mi Portal

Predictors of outcome and the lack of effect of PCI across the risk strata in patients with persistent total occlusion after myocardial infarction results from the occluded artery trial

Mariusz Kruk Jacek Kadziela; Zygmunt P Sadowski; Bruce A Barton; Daniel B Mark; Sandra A Forman; Harmony R Reynolds; Aldo P Maggioni; Jonathan Leor; John G Webb; Michael Kapeliovich; José Antônio Marin-Neto; Harvey D White; Gervasio A Lamas; Judith S Hochman; Scientific Sessions of The American Heart Association(AHA) (2007 Orlando)

Abstracts Orlando, 2007

Orlando 2007

Disponible en FMRP - Fac. Medicina de Ribeirão Preto    (pcd 1642702 ) y otras localizaciones(Obténgalo)

4
Baseline white blood cell count and interleukin-6 levels provide complementary prognostic information in acute myocardial infarction results from the cardinal trial
Baseline white blood cell count and interleukin-6 levels provide complementary prognostic information in acute myocardial infarction results from the cardinal trial
Material Type:
Artículo de Congreso 		Añadir a Mi Portal

Baseline white blood cell count and interleukin-6 levels provide complementary prognostic information in acute myocardial infarction results from the cardinal trial

Manesh R. Patel Kenneth W Mahaffey; Paul W Amstrong; W. Douglas Weaver; Tasissa Gudaye; Judith S Hochman; Thomas G Todaro; Kevin J Malloy; Thomas H Parish; Scott Rollins; Pierre Theroux; Wiltold Ruzyllo; José Carlos Nicolau; Cristopher B Granger; Annual Scientific Session American College of Cardiology (53. 2004 New Orleans, EUA)

Journal American College of Cardiology New York v.43, suppl. A, p. 291A, res. 1118-102, 2004

New York 2004

Disponible en FM - Fac. Medicina    (BCSEP 2004 65 ) y otras localizaciones(Obténgalo)

5
Infarct size, viability, and correlates in patients presenting with a persistent total occlusion of the infarct-related artery 3-28 days post myocardial infarction an occluded artery trial (OAT) substudy
Infarct size, viability, and correlates in patients presenting with a persistent total occlusion of the infarct-related artery 3-28 days post myocardial infarction an occluded artery trial (OAT) substudy
Material Type:
Artículo de Congreso 		Añadir a Mi Portal

Infarct size, viability, and correlates in patients presenting with a persistent total occlusion of the infarct-related artery 3-28 days post myocardial infarction an occluded artery trial (OAT) substudy

Camille A. Pearle James E Udelson; Mariusz Kruk; Harmony R Reynolds; Witold Ruzyllo; Zygmund Sadowski; Anna Teresinska; Barbosz Bychowiec; Thomas Höchtl; José Antonio Marin Neto; Eric A Cohen; Benita Busz Papiez; Paulo Caramori; Gervasio A Adilbrecht; Carey Kimmelstiel; Christopher E Buller; Sandra Forman; Gervasio A Lamas; Judith S Hochman; Annual Scientific Session (56. 2007 New York)

Journal of American College Cardiology New York v. 49, n. 9, on-line, 2007

New York 2007

Disponible en FMRP - Fac. Medicina de Ribeirão Preto    (pcd 1647082 ) y otras localizaciones(Obténgalo)

6
Effect of pexelizumab, an anti-c5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardia infarction the complement inhibition in myocardial infarction treated with thrombolytics (COMPLY) trial
Effect of pexelizumab, an anti-c5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardia infarction the complement inhibition in myocardial infarction treated with thrombolytics (COMPLY) trial
Material Type:
Artículo 		Añadir a Mi Portal

Effect of pexelizumab, an anti-c5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardia infarction the complement inhibition in myocardial infarction treated with thrombolytics (COMPLY) trial

Kenneth W. Mahaffey Christopher B Granger; Jose C Nicolau; Witold Ruzyllo; Douglas Weaver; Pierre Theroux; Judith S Hochman; Thomas G Filloon; Christopher F Mojcik; Thomas G Todaro; Paul W Armstrong

Circulation Philadelphia v. 108, n. 10, p. 1176-1183, september 2003

Philadelphia 2003

Comprobar fondos(Obténgalo)

7
Prognostic Usefulness of White Blood Cell Count and Temperature in Acute Myocardial Infarction (from the CARDINAL Trial)
Prognostic Usefulness of White Blood Cell Count and Temperature in Acute Myocardial Infarction (from the CARDINAL Trial)
Material Type:
Artículo 		Añadir a Mi Portal

Prognostic Usefulness of White Blood Cell Count and Temperature in Acute Myocardial Infarction (from the CARDINAL Trial)

Manesh R. Patel Kenneth W Mahaffey; Paul W Armstrong; W. Douglas Weaver; Gudaye Tasissa; Judith S Hochman; Thomas G Todaro; Kevin J Malloy; Scott Rolins; Pierre Therou; Witold Ruzyllo; José Carlos Nicolau; Christopher B Granger

American Journal of Cardiology Orlando v. 95, n. 5, p. 614-618, March, 2005

Orlando 2005

Disponible en FM - Fac. Medicina    (FM BCBIB )(Obténgalo)

8
Electrophysiological effects of late percutaneous coronary intervention for infarct-related coronary artery occlusion the occluded artery trial-electrophysiological mechanisms (OAT-EP)
Electrophysiological effects of late percutaneous coronary intervention for infarct-related coronary artery occlusion the occluded artery trial-electrophysiological mechanisms (OAT-EP)
Material Type:
Artículo 		Añadir a Mi Portal

Electrophysiological effects of late percutaneous coronary intervention for infarct-related coronary artery occlusion the occluded artery trial-electrophysiological mechanisms (OAT-EP)

Eric J. Rashba Gervasio A Lamas; Jean-Philippe Couderc; Sharri M Hollist; Vladimir Dzavik; Witold Ruzyllo; Viliam Fridrich; Christopher E Buller; Sandra A Forman; Joseph A Kufera; Antonio C Carvalho; Judith S Hochman; Jose Antonio Marin Neto

Circulation Baltimore v. 119, n. 6, p. 779-787, 2009

Baltimore 2009

Disponible en FMRP - Fac. Medicina de Ribeirão Preto    (pcd 1816547 Estantes Deslizantes )(Obténgalo)

9
Initial Invasive or Conservative Strategy for Stable Coronary Disease
Initial Invasive or Conservative Strategy for Stable Coronary Disease
Material Type:
Artículo 		Añadir a Mi Portal

Initial Invasive or Conservative Strategy for Stable Coronary Disease

David J Maron Judith S Hochman; Harmony R Reynolds; Sripal Bangalore; Sean M O'brien; William E Boden; Bernard R Chaitman; Roxy Senior; Jose Lopez-sendon; Whady Armindo Hueb

New england journal of medicine v. 382, n. 15, p. 1395-1407, 2020

Waltham 2020

Acceso en línea. La biblioteca tiene también copias físicas.

10
Effect of pexelizumab, an anti-c5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardia infarction the complement inhibition in myocardial infarction treated with thrombolytics (COMPLY) trial
Effect of pexelizumab, an anti-c5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardia infarction the complement inhibition in myocardial infarction treated with thrombolytics (COMPLY) trial
Material Type:
Artículo 		Añadir a Mi Portal

Effect of pexelizumab, an anti-c5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardia infarction the complement inhibition in myocardial infarction treated with thrombolytics (COMPLY) trial

Kenneth W. Mahaffey Christopher B Granger; Jose C Nicolau; Witold Ruzyllo; Douglas Weaver; Pierre Theroux; Judith S Hochman; Thomas G Filloon; Christopher F Mojcik; Thomas G Todaro; Paul W Armstrong

Circulation Philadelphia v. 108, n. 10, p. 1176-1183, september 2003

Philadelphia 2003

Comprobar fondos(Obténgalo)

Resultados 1 2 3 4 5 next page

Personalizar los resultados

  1. Editar

Refine Search Results

Ampliar mis resultados

  1.   

Mostrar solo

  1. Recursos en línea (637)
  2. Revistas arbitradas (612)
  3. Disponible (17)

Refinar mis resultados

Tipo de Recurso 

  1. Artículos  (651)
  2. Capítulos de libro  (2)
  3. Libros  (1)
  4. Más opciones open sub menu

Fecha de Publicación 

De Hasta
Refinar
  1. Antes de1992  (9)
  2. 1992Hasta2000  (66)
  3. 2001Hasta2007  (169)
  4. 2008Hasta2015  (208)
  5. Después de 2015  (202)
  6. Más opciones open sub menu

Nuevas sugerencias de búsqueda

Ignorar mi consulta y buscar por todo

por este autor/creador:

  1. Hochman, J
  2. Ruzyllo, W
  3. Nicolau, J
  4. Marin Neto, J
  5. Armstrong, P

con este tema:

  1. Science & Technology
  2. Life Sciences & Biomedicine
  3. Humans
  4. Cardiovascular System & Cardiology
  5. Cardiac & Cardiovascular Systems

  • Realización: ABCD-USP USP   Logos de Redes Sociales: Freepik

Buscando en bases de datos remotas, por favor espere

  • Buscando por
  • enscope:(USP_VIDEOS),scope:("PRIMO"),scope:(USP_FISICO),scope:(USP_EREVISTAS),scope:(USP),scope:(USP_EBOOKS),scope:(USP_PRODUCAO),primo_central_multiple_fe
  • Mostrar lo que tiene hasta ahora